Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairmentPaul D. Miller, John H. Krege, Elliott N. Schwartz et al.|Osteoporosis International|2006Cited by 235
PINP as a biological response marker during teriparatide treatment for osteoporosisJohn H. Krege, Paul D. Miller, Nancy E. Lane et al.|Osteoporosis International|2014Cited by 164
Change in Lumbar Spine BMD and Vertebral Fracture Risk Reduction in Teriparatide-Treated Postmenopausal Women With OsteoporosisPeiqi Chen, John H. Krege, Paul D. Miller et al.|Journal of Bone and Mineral Research|2006Cited by 157